SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001394548-16-000003
Filing Date
2016-11-15
Accepted
2016-11-15 18:26:41
Documents
1
Period of Report
2016-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4525
  Complete submission text file 0001394548-16-000003.txt   6230
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROGESX INC. 981 INDUSTRIAL ROAD SUITE F SAN CARLOS CA 94070
Business Address
Ghiglieri Stephen F (Reporting) CIK: 0001394548 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 162000939